Costs were overestimated

BMJ 1995; 311 doi: 10.1136/bmj.311.7016.1372 (Published 18 November 1995)
Cite this as: BMJ 1995;311:1372.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. T M Reynolds
  1. Consultant chemical pathologist Clinical Chemistry Department, Burton Hospitals NHS Trust, Burton upon Trent, Staffordshire DE13 0RB

    EDITOR,--J Fletcher and colleagues' paper on using decision analysis to evaluate screening for Down's syndrome is valuable, but several extra factors need to be considered.1 The authors state that screening causes anxiety but fail to mention the reassurance that it gives to many women. In addition, they based their study on use of the triple test despite the considerable body of evidence showing that a double test is as effective.2 3 Indeed, the national external quality assurance scheme's reports on Down's …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL